STK31通过STAT3-IL-6介导的CD8+ T细胞耗尽驱动瘤免疫逃避
Shasha Li1,2, Jiaming Lin1, Liu Huang3
1Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Oncogene
|March 2, 2025
概括
氨酸/氨酸激酶31 (STK31) 通过激活STAT3信号,驱动非小细胞肺癌 (NSCLC) 的生长和免疫逃避. STK31是NSCLC患者的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 蛋白激酶失调与非小细胞肺癌 (NSCLC) 的发病,进展和耐药性有关.
- 识别新型瘤驱动因素对于开发针对性治疗NSCLC至关重要.
研究的目的:
- 在NSCLC中识别和功能性表征新型失调基因.
- 调查氨酸/氨酸激酶31 (STK31) 在NSCLC病原和免疫逃逸中的作用.
主要方法:
- 对TCGA数据库和文献进行全面分析.
- 在免疫能力和裸体小鼠模型中的功能研究.
- 研究STK31的机制,涉及CD8+T细胞,STAT3和IL-6信号传递.
主要成果:
- STK31被确定为NSCLC中经常失调的基因.
- 在体内,STK31的上调促进了瘤生长和CD8+T细胞耗尽.
- STK31激活了STAT3-IL-6通路,促进了免疫逃生.
- 增加STK31表达与NSCLC患者的预后不佳相关.
结论:
- STK31在通过STAT3激活促进NSCLC免疫逃脱方面发挥着关键作用.
- STK31是NSCLC治疗中一个有前途的治疗点.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
557
相关概念视频
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
